396 related articles for article (PubMed ID: 28884937)
81. Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.
Inokuchi K; Mori H; Matsuzaki J; Hirata K; Harada Y; Saito Y; Suzuki H; Kanai T; Masaoka T
Helicobacter; 2022 Aug; 27(4):e12900. PubMed ID: 35644041
[TBL] [Abstract][Full Text] [Related]
82. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
[TBL] [Abstract][Full Text] [Related]
83. P-CAB
Jiang Y; Zhang R; Fang Y; Zhao R; Fu Y; Ren P; Zhan Q; Shao M
Therap Adv Gastroenterol; 2024; 17():17562848241241223. PubMed ID: 38751605
[TBL] [Abstract][Full Text] [Related]
84. Efficacy of second-line regimens for
Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
[TBL] [Abstract][Full Text] [Related]
85. Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.
Kusano C; Gotoda T; Suzuki S; Ikehara H; Moriyama M
J Gastroenterol; 2018 Jun; 53(6):718-724. PubMed ID: 29110085
[TBL] [Abstract][Full Text] [Related]
86. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
[TBL] [Abstract][Full Text] [Related]
87. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
88. Impact of Vonoprazan Triple-Drug Blister Packs on H. pylori Eradication Rates in Japan: Interrupted Time Series Analysis.
Deguchi H; Yamazaki H; Kamitani T; Yamamoto Y; Fukuhara S
Adv Ther; 2021 Jul; 38(7):3937-3947. PubMed ID: 34091865
[TBL] [Abstract][Full Text] [Related]
89. Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in China.
Gao W; Teng G; Wang C; Xu Y; Li Y; Cheng H
Helicobacter; 2022 Oct; 27(5):e12918. PubMed ID: 35877765
[TBL] [Abstract][Full Text] [Related]
90. Efficacy, safety and cost-effectiveness of vonoprazan vs Proton Pump Inhibitors in reflux disorders and H. pylori eradication: A literature review.
Shehryar M; Ahmad RU; Kareem HK; Khan L; Ashraf MF; Hassan A; Saeed S; Tareen HK; Nazir DA; Ashraf MA
Ann Med Surg (Lond); 2022 Oct; 82():104760. PubMed ID: 36268393
[TBL] [Abstract][Full Text] [Related]
91. Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study.
Hirata Y; Yamada A; Niikura R; Shichijo S; Hayakawa Y; Koike K
Helicobacter; 2020 Oct; 25(5):e12719. PubMed ID: 32602161
[TBL] [Abstract][Full Text] [Related]
92. Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin.
Takara Y; Endo H; Nakano R; Kawachi K; Hidaka H; Matsunaga T; Tsuruoka N; Sakata Y; Shimoda R; Hara M; Fujimoto K
Digestion; 2019; 99(2):172-178. PubMed ID: 30179876
[TBL] [Abstract][Full Text] [Related]
93. Efficacy and safety of high-dose dual therapy for Helicobacter pylori rescue therapy: A systematic review and meta-analysis.
Gao CP; Zhou Z; Wang JZ; Han SX; Li LP; Lu H
J Dig Dis; 2016 Dec; 17(12):811-819. PubMed ID: 27977071
[TBL] [Abstract][Full Text] [Related]
94. Vonoprazan-containing therapy has an
Lui RN; Chan FKL
Ann Intern Med; 2021 Oct; 174(10):JC117. PubMed ID: 34606307
[TBL] [Abstract][Full Text] [Related]
95. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
96. Vonoprazan-based versus proton pump inhibitor-based therapy in
Chen PY; Tsai FP; Chen MJ; Yang HY; Wu MS; Liou JM
Gut; 2024 Apr; 73(5):872-874. PubMed ID: 37001979
[No Abstract] [Full Text] [Related]
97. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
98. Clinical Study on the Eradication of Helicobacter pylori by Vonoprazan Combined with Amoxicillin for 10-Day Dual Therapy.
Yan K; Dai X; Li Z; Rong W; Chen L; Diao X
Clin Pharmacol Drug Dev; 2024 Mar; 13(3):240-247. PubMed ID: 38197874
[TBL] [Abstract][Full Text] [Related]
99. Comparison of 7- and 14-Day Eradication Therapy for
Kim TH; Park JM; Cheung DY; Oh JH
J Korean Med Sci; 2020 Feb; 35(5):e33. PubMed ID: 32030921
[TBL] [Abstract][Full Text] [Related]
100. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
Rokkas T; Gisbert JP; Malfertheiner P; Niv Y; Gasbarrini A; Leja M; Megraud F; O'Morain C; Graham DY
Gastroenterology; 2021 Aug; 161(2):495-507.e4. PubMed ID: 33839101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
